Milyon USD cinsinden finanslar. Mali yıl Şubat - Ocak'tır.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Hasılat
6,561
6,603
7,384
7,085
5,213
3,192
Hasılat Artışı (YoY)
-4%
-11%
4%
36%
63%
14%
Satınalma Maliyeti
4,855
4,358
4,538
4,277
2,942
1,678
Brüt Kâr
1,706
2,244
2,845
2,808
2,270
1,514
Satış, Genel ve İdari
965
860
782
722
652
435
Araştırma ve Geliştirme
257
229
254
229
211
151
İşletme Giderleri
1,174
1,154
1,132
1,028
841
557
Diğer Finansman Gelirleri (Giderleri)
-8
0
1
2
-12
-4
Kâr Öncesi Gelir
800
664
2,488
2,585
3,684
2,218
Kira Vergisi Gideri
163
216
338
313
292
189
Net Kâr
612
405
2,024
2,006
2,874
1,749
Net Income Growth
Kâr Artışı
-36%
-80%
1%
-30%
64%
108%
Dolaşım Daki Hisse Senetleri (Dilüte Edilmiş)
868.8
863.04
865.32
864.89
870.95
799
Hisse Değişimi (Yıllık Üst Üste)
0%
0%
0%
-1%
9%
7%
EPS (Diluted)
0.7
0.46
2.34
2.32
3.3
2.19
EPS Artışı
-36%
-80%
1%
-30%
51%
94%
Öz sermaye akışı
1,005
740
836
908
1,055
842
Hisse Başı Öz Kaynak Akışı
--
--
--
--
--
--
Brüt Karşılık
26%
33.98%
38.52%
39.63%
43.54%
47.43%
Faaliyet Kâr Marjı
8.09%
16.49%
23.18%
25.1%
27.41%
29.94%
Kâr Marjı
9.32%
6.13%
27.41%
28.31%
55.13%
54.79%
Özsermaye Karlılık Oranı
15.31%
11.2%
11.32%
12.81%
20.23%
26.37%
EBITDA
--
1,241
1,838
1,889
1,500
1,013
EBITDA Marjinali
--
18.79%
24.89%
26.66%
28.77%
31.73%
D&A EBITDA için
--
152
126
110
71
57
Faaliyet Kârı
531
1,089
1,712
1,779
1,429
956
Faaliyet Kâr Marjı
8.09%
16.49%
23.18%
25.1%
27.41%
29.94%
Verilen Vergi Oranı
20.37%
32.53%
13.58%
12.1%
7.92%
8.52%
Follow-Up Questions
Hangzhou Tigermed Consulting Co Ltd'in temel mali tabloları nelerdir?
HTMDF'ün temel finansal oranları nelerdir?
Hangzhou Tigermed Consulting Co Ltd'in geliri segment veya coğrafya bazında nasıl dağılıyor?
Hangzhou Tigermed Consulting Co Ltd kârlı mı?
Hangzhou Tigermed Consulting Co Ltd'in herhangi bir yükümlülüğü var mı?
Hangzhou Tigermed Consulting Co Ltd'in tedavüldeki hisse sayısı kaçtır?
Önemli İstatistikler
Önceki Kapanış
--
Açılış fiyatı
--
Günün Aralığı
-
52 haftalık aralık
-
İşlem hacmi
--
Ort.Hacim
--
EPS (TTM)
--
Dividend yield
--
Piyasa Değeri
--
HTMDF nedir?
Hangzhou Tigermed Consulting Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Hangzhou, Zhejiang and currently employs 10,185 full-time employees. The company went IPO on 2012-08-17. Hangzhou Tigermed Consulting Co Ltd is a China-based holding company engaged in providing clinical trial services for research and development of new drugs. The firm operates two segments. The Clinical Trial Solutions segment provides clinical trial operation services and medical translation services to biopharmaceutical and medical device companies and thus help them conduct clinical trials of innovative drugs, generic drugs and medical devices. The Clinical-Related and Laboratory Services segment is involved in provision of analytical services, such as data management and statistical analysis; logistics and execution support services, such as clinical trial site management; administrative assistance, such as patient recruitment; as well as consulting services. This segment also provides laboratory services for preclinical and clinical development stages through its subsidiary. The firm conducts its businesses in the domestic and overseas markets.